Association between D-dimer levels and various microvascular diabetic complications
- VernacularTitle:Диабетийн жижиг судасны зарим хүндрэл ба Д-Димерийн түвшин хоорондын хамаарлыг судалсан дүн
- Author:
Narkhajid G
1
;
2
;
Munkh-Uchral N
2
;
3
;
Baigalmaa E
1
;
Suvd J
1
;
Oyuntugs B
1
;
2
;
Otgonbat A
2
;
3
Author Information
1. Department of Endocrinology, School of Medicine, MNUMS
2. Department of Internal Medicine, Mongolia-Japan Hospital, MNUMS
3. Department of Hematology, School of Medicine, MNUMS
- Publication Type:Journal Article
- Keywords:
type 2 diabetes;
diabetic complications;
thrombosis;
fibrin
- From:
Mongolian Journal of Health Sciences
2026;97(7):43-47
- CountryMongolia
- Language:Mongolian
-
Abstract:
Background:Thrombotic alterations play a central role in the pathogenesis of both macrovascular and microvascular complications of diabetes mellitus. D-dimer, a fibrin degradation product generated during fibrinolysis, has emerged as a potential biomarker for predicting chronic diabetic complications and assessing their severity.
Aim:To determine D-dimer levels in individuals with type 2 diabetes mellitus (T2DM) and investigate their association with various microvascular complications.
Materials and Methods:This cross-sectional study included 215 participants with T2DM. Individuals diagnosed with other forms of diabetes, those receiving anticoagulant therapy, and those with liver disease were excluded according to the predefined exclusion criteria. Participants were categorized into two groups according to their D-dimer levels: ≤0.260 μg/mL and >0.260 μg/mL. The prevalence of diabetic retinopathy, nephropathy, and neuropathy was compared between the groups. Multivariable logistic and linear regression models were adjusted for age, sex, and body mass index (BMI).
Results:A total of 215 individuals with T2DM were included in the study. The median D-dimer level was 0.260 μg/mL (interquartile range [IQR]: 0.190–0.460). The prevalence of at least one microvascular complication was significantly higher among participants with D-dimer levels above the median than among those with levels at or below the median (51.4% vs. 37.0%, p=0.034). The prevalence of diabetic nephropathy was 33.6% versus 13.0% (p<0.001), while that of diabetic neuropathy was 20.6% versus 10.2% (p=0.035), respectively, indicating a higher burden of chronic complications in the group with elevated D-dimer levels. Participants with D-dimer levels above the median had 2.23 times higher odds of having at least one diabetic microvascular complication (OR=2.23; 95% CI: 1.19–4.18; p=0.013).
Conclusions:1. Elevated D-dimer levels were observed in 21.4% of individuals with type 2 diabetes mellitus included in the study. 2. D-dimer levels above the median (0.260 μg/mL) were associated with a twofold increase in the odds of having diabetic microvascular complications (OR=2.23; 95% CI: 1.19–4.18; p=0.013).
- Full text:20261102212952621977. Диабетийн жижиг судасны зарим хүндрэл ба Д-Димерийн түвшин хоорондын хамаарлыг.pdf
